Business Standard

Analysts' corner

IDFC & Biocon

Read more on:    Idfc & Biocon
Related News

IDFC
Reco price/date: Rs 116/May 21;
Current/Target price: Rs 120.4/Rs 147
IDFC has delivered strong performance on growth and margin front. Expected monetary easing and reformatory steps by the government would be major catalysts in further improving the growth and profitability outlook. Healthy asset quality track record and prudent provisioning policy makes IDFC better placed compared to its peers in infra financing. The growth in IDFC’s outstanding disbursements remained well-diversified across telecom, energy and transportation segments. Analysts expect IDFC to report an EPS of Rs 11 and Rs 13 and estimated adjusted book value (for investment in other ventures) of Rs 82 and Rs 92 for 2012-13 and 2013-14, respectively. Maintain Buy.

Motilal Oswal Securities

BIOCON
Reco price/date: Rs 217/May 21;
Current/Target price: Rs 215/Rs 186
Biocon's (BIOS) shares have had an uninspiring run after the termination of the Pfizer deal, which dealt a big blow to its biosimilar insulin aspirations. While the deal is now terminated, it would continue to throw its shadow over future earnings, thanks to an aggressive accounting policy that would see BIOS shift biosimilar insulin R&D costs off the P&L. This, along with use of a creative transaction structure for AxiCorp, leaves analyst frustrated with corporate governance standards in the company, and they have downgraded their accounting and corporate governance rating from amber to red. Stripping out biosimilar insulin (90 per cent valuation haircut) and Dificid, BIOS is currently trading at 12 times FY13 estimated earnings. Espirito has cut its fair value by 47 per cent to Rs 186 (from Rs 350 earlier). Downgrade to sell.

Espirito Santo Securities


Note: Reco price/date refers to the price and date at which the recommendation was made. Target price refers to the fair value of the stock as per the said brokerage

Read more on:   

Read More

Today's picks

The index closed bearish.

Quick Links

 

Market News

P-note share in FII assets races ahead

At Rs 2.07 lakh crore, value of investments through P-notes hits a 3-year high

Iron ore production yet to pick up in Karnataka

One year after the Apex Court allowing opening of 115 mines in category A and B, the production has barely touched 20 million tonnes

Surat diamantaires' co-operative dream lies shattered

Company set up to source rough diamonds in abeyance

Five firms buying back shares worth Rs 6,000 cr this year

Cairn India's whopping Rs 5,725-cr buyback offer is the major among five programmes this year

Stagnant auditors

Under the new Companies Act 2013, it is mandatory for companies to change auditors every 10 years

Back to Top